Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 3
2017 2
2018 2
2019 3
2021 2
2022 1
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
The relevance of persisters in tuberculosis drug discovery.
Mandal S, Njikan S, Kumar A, Early JV, Parish T. Mandal S, et al. Among authors: early jv. Microbiology (Reading). 2019 May;165(5):492-499. doi: 10.1099/mic.0.000760. Epub 2019 Feb 18. Microbiology (Reading). 2019. PMID: 30775961 Free article. Review.
8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
Odingo JO, Early JV, Smith J, Johnson J, Bailey MA, Files M, Guzman J, Ollinger J, Korkegian A, Kumar A, Ovechkina Y, Parish T. Odingo JO, et al. Among authors: early jv. Drug Dev Res. 2019 Aug;80(5):566-572. doi: 10.1002/ddr.21531. Epub 2019 Mar 20. Drug Dev Res. 2019. PMID: 30893501 Free PMC article.
Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
Chandrasekera NS, Alling T, Bailey MA, Files M, Early JV, Ollinger J, Ovechkina Y, Masquelin T, Desai PV, Cramer JW, Hipskind PA, Odingo JO, Parish T. Chandrasekera NS, et al. Among authors: early jv. J Med Chem. 2015 Sep 24;58(18):7273-85. doi: 10.1021/acs.jmedchem.5b00546. Epub 2015 Sep 2. J Med Chem. 2015. PMID: 26295286
Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis.
Hembre E, Early JV, Odingo J, Shelton C, Anoshchenko O, Guzman J, Flint L, Dennison D, McNeil MB, Korkegian A, Ovechkina Y, Ornstein P, Masquelin T, Hipskind PA, Parish T. Hembre E, et al. Among authors: early jv. Front Chem. 2021 Apr 29;9:613349. doi: 10.3389/fchem.2021.613349. eCollection 2021. Front Chem. 2021. PMID: 33996738 Free PMC article.
Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents.
Kesicki EA, Bailey MA, Ovechkina Y, Early JV, Alling T, Bowman J, Zuniga ES, Dalai S, Kumar N, Masquelin T, Hipskind PA, Odingo JO, Parish T. Kesicki EA, et al. Among authors: early jv. PLoS One. 2016 May 12;11(5):e0155209. doi: 10.1371/journal.pone.0155209. eCollection 2016. PLoS One. 2016. PMID: 27171280 Free PMC article.
Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
O'Malley T, Alling T, Early JV, Wescott HA, Kumar A, Moraski GC, Miller MJ, Masquelin T, Hipskind PA, Parish T. O'Malley T, et al. Among authors: early jv. Antimicrob Agents Chemother. 2018 May 25;62(6):e02439-17. doi: 10.1128/AAC.02439-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29632008 Free PMC article.
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis.
Martinez-Grau MA, Valcarcel ICG, Early JV, Gessner RK, de Melo CS, de la Nava EMM, Korkegian A, Ovechkina Y, Flint L, Gravelle A, Cramer JW, Desai PV, Street LJ, Odingo J, Masquelin T, Chibale K, Parish T. Martinez-Grau MA, et al. Among authors: early jv. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1758-1764. doi: 10.1016/j.bmcl.2018.04.028. Epub 2018 Apr 13. Bioorg Med Chem Lett. 2018. PMID: 29680666 Free PMC article.
14 results